BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9615901)

  • 1. Effect of thyroid hormone on plasma apolipoproteins and apoA- and apoB-containing lipoprotein particles.
    Liu XQ; Rahman A; Bagdade JD; Alaupovic P; Kannan CR
    Eur J Clin Invest; 1998 Apr; 28(4):266-70. PubMed ID: 9615901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro transformation of apoA-I-containing lipoprotein subpopulations: role of lecithin:cholesterol acyltransferase and apoB-containing lipoproteins.
    Cheung MC; Wolf AC
    J Lipid Res; 1989 Apr; 30(4):499-509. PubMed ID: 2502592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
    Chan DC; Watts GF; Nguyen MN; Barrett PH
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.
    Bekaert ED; Alaupovic P; Knight-Gibson CS; Franceschini G; Sirtori CR
    J Lipid Res; 1993 Jan; 34(1):111-23. PubMed ID: 8445335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial.
    Alaupovic P; Fesmire JD; Hunnighake D; Domanski M; Forman S; Knatterud GL; Forrester J; Herd JA; Hoogwerf B; Campeau L; Gobel FL
    Atherosclerosis; 1999 Oct; 146(2):369-79. PubMed ID: 10532693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.
    Le NA; Innis-Whitehouse W; Li X; Bakker-Arkema R; Black D; Brown WV
    Metabolism; 2000 Feb; 49(2):167-77. PubMed ID: 10690940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
    Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between thyroid function and lipid profiles, apolipoproteins, and high-density lipoprotein function.
    Jung KY; Ahn HY; Han SK; Park YJ; Cho BY; Moon MK
    J Clin Lipidol; 2017; 11(6):1347-1353. PubMed ID: 28958565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
    Hughes TA; Stentz F; Gettys T; Smith SR
    Metabolism; 2006 Jan; 55(1):26-34. PubMed ID: 16324916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with hyperthyroidism.
    Klausen IC; Hegedüs L; Hansen PS; Nielsen FE; Gerdes LU; Faergeman O
    J Mol Med (Berl); 1995 Jan; 73(1):41-6. PubMed ID: 7633941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
    Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
    J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor.
    Bisgaier CL; Essenburg AD; Barnett BC; Auerbach BJ; Haubenwallner S; Leff T; White AD; Creger P; Pape ME; Rea TJ; Newton RS
    J Lipid Res; 1998 Jan; 39(1):17-30. PubMed ID: 9469582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
    Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
    Nephron; 1997; 75(3):286-94. PubMed ID: 9069450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment.
    Tzotzas T; Krassas GE; Konstantinidis T; Bougoulia M
    Thyroid; 2000 Sep; 10(9):803-8. PubMed ID: 11041458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism.
    Kung AW; Pang RW; Lauder I; Lam KS; Janus ED
    Clin Chem; 1995 Feb; 41(2):226-31. PubMed ID: 7874776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of simvastatin on plasma lipids and apolipoproteins in familial hypercholesterolemic swine.
    Hasler-Rapacz J; Kempen HJ; Princen HM; Kudchodkar BJ; Lacko A; Rapacz J
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):137-43. PubMed ID: 8548414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.
    Dashti N; Alaupovic P; Knight-Gibson C; Koren E
    Biochemistry; 1987 Jul; 26(15):4837-46. PubMed ID: 2822101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
    Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
    Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.